American investment banking firm TD Cowen has reiterated its Buy rating on chipmaker Nvidia’s (NVDA) stock, stating it as, “The Accelerated Computing Leader.” Yesterday, analyst Joshua Buchalter at TD Cowen maintained a $175 price target on NVDA stock, highlighting its dominance in accelerated computing. Cowen believes with healthcare emerging as a major AI opportunity, Nvidia is positioned to play a crucial role in advancing the industry. Meanwhile, the price target implies a 64% upside from current levels.
Notably, accelerated computing is a method of enhancing processing speed by offloading complex tasks from traditional CPUs to specialized hardware like GPUs (Graphics Processing Units), TPUs (Tensor Processing Units), and custom AI chips.
TD Cowen Highlights Nvidia’s AI Potential in Healthcare
TD Cowen has reaffirmed its bullish case on NVDA stock after it hosted NVIDIA’s VP of Healthcare, Kimberly Powell, at its 45th Annual Health Care Conference. Powell pointed out that Nvidia’s Blackwell architecture, with its performance boost and cost efficiencies, could drive further adoption in the healthcare sector.
On top of that, TD Cowen noted healthcare is a $10 trillion global industry, with 30% tied to labor, labs, and infrastructure—areas Nvidia sees as prime for accelerated computing. By FY26, Nvidia’s healthcare revenue could surpass $1 billion from hardware and software. While significant, it remains a small part of its larger data center growth potential.
At the same time, NVIDIA sees three key AI-driven healthcare growth areas: drug discovery, digital devices, and digital health. It estimates a $300 billion market shift toward compute spending in drug discovery, while its Cosmos model and Omniverse in digital devices could revolutionize AI-powered surgical robotics.
All in all, Cowen asserts that Nvidia is evolving from a GPU-focused company into a comprehensive hardware and software platform provider, integrating AI, cloud computing, and deep learning solutions. That said, it leads key industry shifts, leveraging multiple growth opportunities such as healthcare.
Is Nvidia Stock a Buy, Sell, or Hold?
NVDA stock is off to a rough start in 2025, with shares down over 20% year-to-date. Growth concerns, supply chain challenges, and tariff-related risks are weighing on its performance. Nonetheless, analysts maintain their bullish stance with a Strong Buy consensus rating.
According to TipRanks, NVDA stock has received 39 Buys and three Holds in the last three months. At $177.41, the Nvidia average share price target implies a 66% upside potential.
Questions or Comments about the article? Write to editor@tipranks.com